Sign in
4/A

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-22-040273

Options or other derivatives

  • Chief Development Officer acquired 137,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Forbes William P · Chief Development Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-11 Grant or award : show line 1 in the form Stock Option (right to buy) +137,500 137,500 D
Loading xslF345X03/doc4a.xml…